Anca Bojan

Hepatitis B and C virus infection in Romanian non‐Hodgkin's lymphoma patients

Andrei Cucuianu, Mariana Paţiu, Milena Duma et al. · British Journal of Haematology · 1999 · 75 citations

Medicine, Hematology, Oncology +11

<i><scp>TERT</scp></i> rs2736100 A&gt;C <scp>SNP</scp> and <i><scp>JAK</scp>2</i> 46/1 haplotype significantly contribute to the occurrence of <i><scp>JAK</scp>2</i> V617F and <i><scp>CALR</scp></i> mutated myeloproliferative neoplasms – a multicentric study on 529 patients

Adrian P. Trifa, Claudia Bănescu, Mihaela Tevet et al. · British Journal of Haematology · 2016 · 35 citations

Medicine, Hematology, Molecular Genetics +16

Design of FLT3 Inhibitor - Gold Nanoparticle Conjugates as Potential Therapeutic Agents for the Treatment of Acute Myeloid Leukemia

Timea Nagy-Simon, Ciprian Tomuleasa, Anca Bojan et al. · Nanoscale Research Letters · 2015 · 34 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

<i>MECOM</i>, <i>HBS1L‐MYB</i>, <i>THRB‐RARB, JAK2</i>, and <i>TERT</i> polymorphisms defining the genetic predisposition to myeloproliferative neoplasms: A study on 939 patients

Adrian P. Trifa, Claudia Bănescu, Anca Bojan et al. · American Journal of Hematology · 2017 · 29 citations · Full text

Life Sciences, Genetics, Hematology +14

Chemotherapy-related infectious complications in patients with Hematologic malignancies

Ștefan Cristian Vesa, R Rusu, Dana Sîrbu et al. · Journal of Research in Medical Sciences · 2018 · 23 citations · Full text

Medicine, Hematology, Infectious Diseases +17